Carolin Anita Keßler on LinkedIn: Zielgenaue Krebstherapien: Roche-Tochter Foundation Medicine ausgezeichnet…
![Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire](https://mms.businesswire.com/media/20200212005980/en/773224/5/FMI_vertical-slate.jpg)
Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire
![Roche launches FDA-approved diagnostic test for personalised cancer care in Singapore | MobiHealthNews Roche launches FDA-approved diagnostic test for personalised cancer care in Singapore | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/F1CDx-Kit_Mobi.jpg)
Roche launches FDA-approved diagnostic test for personalised cancer care in Singapore | MobiHealthNews
![Roche's buyout of Foundation Medicine: reaping benefits from Merck's Keytruda - Pharmaceutical Technology Roche's buyout of Foundation Medicine: reaping benefits from Merck's Keytruda - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2018/06/Roches.jpg)
Roche's buyout of Foundation Medicine: reaping benefits from Merck's Keytruda - Pharmaceutical Technology
![Foundation Medicine sold for $2.4 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research Foundation Medicine sold for $2.4 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research](https://www.stockwinners.com/blog/wp-content/uploads/2018/06/fm-300x146.jpg)
Foundation Medicine sold for $2.4 billion – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research
![Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History](https://cdn.sanity.io/images/ti7si9cx/production/027cc19cfe86f324fb5ec461e5b519bb58a0ea29-1500x750.jpg?w=1382)
Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History
![Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer | Business Wire Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer | Business Wire](https://mms.businesswire.com/media/20230302005150/en/1727718/23/Foundationmedicine_p32h_logo_v2.jpg)
Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer | Business Wire
![Foundation Medicine appoints new CEO; exec provides forecasts for precision medicine in 2019 - MedCity News Foundation Medicine appoints new CEO; exec provides forecasts for precision medicine in 2019 - MedCity News](https://medcitynews.com/wp-content/uploads/2018/05/GettyImages-683253578-600x400.jpg)
Foundation Medicine appoints new CEO; exec provides forecasts for precision medicine in 2019 - MedCity News
![Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy](https://www.gustaveroussy.fr/sites/default/files/cppartenariat-fresh-share-180923.png)
Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
![Roche, Foundation Medicine start global launch of cancer genomic profiling kit for labs worldwide | Fierce Biotech Roche, Foundation Medicine start global launch of cancer genomic profiling kit for labs worldwide | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1635168991/dna-163466_1280.jpg/dna-163466_1280.jpg?VersionId=JSBlGGqb6IZBHrqTjATD6.PNrMtN5PRH)
Roche, Foundation Medicine start global launch of cancer genomic profiling kit for labs worldwide | Fierce Biotech
![Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine - Labiotech.eu](https://www.labiotech.eu/wp-content/uploads/2015/01/Foundation-Medicine-acquired-by-Roche-1200x900.jpg)